Donna D. Strong, PhD - Presentations

Presentation

CA Strohbach, TA Linkhart, s Mohan Y Shi, C Glackin, DD Strong. "Non-canonical Wnt11 transcriptionally suppresses expression of insulin-like growth factor binding protein-6, an inhibitor of osteoblast differentiation. ." ASBMR. Nashville, TN (09/2005)
DD Strong, DA Dean, TA Linkhart.. "Development of an osteoblast-specific DNA nuclear targeting sequence from the human type1a2 procollagen promoter for development of efficient plasmid expression vectors. ." American Society of Bone Mineral Research. Nashville, TN (09/2005)
Hall SL, Felt JC, Linkhart TA, Strong DD. "Effects of R-FB, a unique nonsteroidal anti-inflammatory drug, on cox2 mediated inhibition of insulin-like growth factor binding protein-6 (BP6) transcription." ASBMR. Nashville, TN (09/2005)

David A. Dean, Cindy Stivers, Tom A. Linkhart, Donna D. Strong.. "Sequences from the human type 1alpha2 procollagen promoter mediate osteoblast-specific plasmid nuclear import." American Society of Gene Therapy. Baltimore, MD (06/2006)
Rundle CH, Strong DD, Chen S-T, Sheng MH-C, Wergedal JE, Lau K-HW, Baylink DJ. . "Retroviral-Based Gene Therapy with Cyclo-Oxygenase-2 Promotes Bony Union and Accelerates Fracture Healing in the Rat. ." American Society of Gene Therapy. Baltimore, MD (06/2006)
C.A. Strohbach, C.H. Rundle, C.S-T Chen, J.E. Wergedal, T.A. Linkhart, D.J. Baylink, K-H.W. Lau, D.D. Strong. "In vivo retroviral-based gene therapy with LIM Mineralization Protein (LMP)-1 enhances fracture healing.." 53th annual meeting Orthopaedic Research Society. San Diego, CA (02/2007)